Diamond Biotechnology Co., Ltd (TPEX:6815)
Taiwan · Delayed Price · Currency is TWD 64.50
-1.50 (-2.27%)
Jan 22, 2026, 1:47 PM CST
Diamond Biotechnology Market Cap
Diamond Biotechnology has a market cap or net worth of 2.62 billion as of January 21, 2026. Its market cap has increased by 0.54% in one year.
Market Cap
2.62B
Enterprise Value
2.67B
Revenue
698.11M
Ranking
n/a
PE Ratio
74.38
Stock Price
64.50
Market Cap Chart
Since January 29, 2021, Diamond Biotechnology's market cap has increased from 1.68B to 2.62B, an increase of 56.07%. That is a compound annual growth rate of 9.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 2.62B | 4.76% |
| Dec 31, 2025 | 2.50B | -7.50% |
| Dec 31, 2024 | 2.71B | 12.05% |
| Dec 29, 2023 | 2.42B | 179.34% |
| Dec 30, 2022 | 864.86M | -11.33% |
| Dec 30, 2021 | 975.37M | -41.97% |
| Jan 29, 2021 | 1.68B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonraybio | 3.96B |
| Medimaging Integrated Solution | 3.38B |
| WeLeader Biomedical | 3.24B |
| InnoCare Optoelectronics | 2.79B |
| A Plus Biotechnology | 2.76B |
| Applied BioCode | 2.46B |
| Dynamic Medical Technologies | 2.40B |
| Wellell | 2.35B |